Patent details

EP1409025 Title: VECTOR ENCODING HUMAN GLOBLIN GENE AND USE THEREOF IN TREATMENT OF HEMOGLOBINOPATHIES

Basic Information

Publication number:
EP1409025
PCT Application Number:
PCT/US/2002/020988
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027497536
PCT Publication Number:
WO/2003/002155
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
VECTOR ENCODING HUMAN GLOBLIN GENE AND USE THEREOF IN TREATMENT OF HEMOGLOBINOPATHIES
French Title of Invention:
VECTEUR CODANT POUR LE GENE-GLOBINE HUMAIN ET UTILISATION DE CELUI-CI DANS LE TRAITEMENT D'HEMOGLOBINOPATHIES
German Title of Invention:
VEKTOR KODIEREND HUMANES GLOBIN-GEN UND SEINE VERWENDUNG BEI DER BEHANDLUNG VON HÄMOGLOBINOPATHIEN
SPC Number:

Dates

Filing date:
01/07/2002
Grant date:
30/11/2011
EP Publication Date:
30/11/2011
PCT Publication Date:
09/01/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/04/2004
EP B1 Publication Date:
30/11/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/07/2012
Expiration date:
01/07/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/07/2002
 
 

Name:
Sloan Kettering Institute For Cancer Research
Address:
1275 York Avenue, New York, NY 10021, United States (US)

Inventor

1

Name:
MAY Chad
Address:
United States (US)

2

Name:
SADELAIN Michel
Address:
United States (US)

3

Name:
RIVELLA Stefano
Address:
United States (US)

4

Name:
BERTINO Joseph
Address:
United States (US)

Priority

1

Priority Number:
301861 P
Priority Date:
29/06/2001
Priority Country:
United States (US)

2

Priority Number:
302852 P
Priority Date:
02/07/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 48/00;
Filing date Document type Number of pages